Other Links
Our enduring commitment to excellence is exemplified by our extensive portfolio of products, categorised across 16 therapeutic areas.
Anti-infective: Antifungals I Antibacterials I Antivirals I Antimycobacterials
Alimentary track
Diabetes
Musculoskeletal: Antigout I Muscle relaxant
Antihistamines
Antiinflammatory, Antirheumatics and Analgesics
Antineoplastics and lmmunomodulating: Immune system I Antineoplastics
Blood and Blood forming: Antianemics I Antithrombotics I Antihemorrhagics
Cardiovascular: Antihypertensives I Antiarrhythmics I Lipid Modifying agents | Vasodilators
Genito-urinary
Hormones-Corticosteroids: Antithyroids I Antiparathyroids I Corticosteroids I Oral contraceptives
Nervous: Antidepressants I Antiepileptics I Antiparkinson I Hypnotics | Antipsychotics I Anxiolytics I Antivertigo
Ophthalmological
Respiratory
Antiparasitic: Antiprotozoals I Anthelmintics
Medical Devices and Cosmetics
Remedica offers a comprehensive portfolio of high-quality generic medicines, catering to both business-to-business (B2B) clients and direct customers through our dedicated agents. We serve a broad spectrum of needs in both the International Market and the Cyprus Market, ensuring reliable access to essential healthcare solutions.
See EU-made dossiers available for out-licensing worldwide
See products available for distribution in international markets
See product distribution list in the Cyprus market
At Remedica, our patient’s safety is of utmost importance, and our Drug Safety Department bears the crucial responsibility of safeguarding patients and public health. This mission encompasses the prevention of harm stemming from Adverse Drug Reactions (ADRs) and counterfeit medicines while advocating for the secure and effective use of medicinal products. In the realm of medicinal products, human responses can vary significantly. Notably, not all adverse reactions can be unearthed through even the most rigorous of clinical trials. Thus, Remedica is deeply committed to recording these ADRs however infrequently they occur as part of our ongoing pursuit of patient and drug safety. Furthermore, Remedica actively engages in the battle against illicit medicine; an illegal trade that can, in some cases, lead to severe health issues.
In the realm of operations, Remedica stands as a testament to both innovation and precision. Our expansive facility, nestled in the heart of Limassol, Cyprus, sprawls over 55,000 square meters, housing an intricate network of 12 buildings. Among these, three dedicated manufacturing units each contribute to the production and packaging of an array of pharmaceutical categories.
Within our organization, we currently operate three specialized factories, each honing its experience in its own field such as antibiotics, anti-cancer agents and hormones, and also general pharmaceuticals. Our commitment to innovation in the industry is manifest in our approach to automation and cutting-edge equipment, which has been seamlessly integrated into our production and packaging lines. In crafting pharmaceutical solutions, we cover an array of dosage forms, including tablets, capsules, oral liquids, gels, creams, ointments, powder syrups, topical aerosols, and suppositories. Our meticulous warehousing and management systems guarantee secure and efficient storage and distribution of raw pharmaceutical materials, packaging components, semi-finished, and finished products.
Environmental responsibility is embedded in our operations, with continuous monitoring and control of temperature and humidity throughout our warehouses. We uphold the highest standards of quality and safety, employing serialization and aggregation capabilities to combat fraud and bolster patient well-being. We are committed to technological advancement, and our current and future initiatives encompass automation and upgrading of production and packaging lines with state-of-the-art equipment. We embrace digital transformation and we apply an effective waste prevention management program. We also utilize renewable energy sources and apply an effective climate action program, to optimize energy efficiency and drastically reduce our carbon footprint.
Recent developments include the expansion of production within Building 1, creating an effective and modern Factory within a Factory. Advanced warehouses have been erected to accommodate our growing operations, such as the impressive B12 Exports Warehouse, a towering beacon of modernity and efficiency. This export centre incorporates hybrid automation technologies and innovative robotic cleaning systems in both production areas and warehouses. A testament to our relentless pursuit of technological excellence, this new facility demonstrates our forward-thinking approach. Combined with our steadfast commitment to quality and safety, Remedica finds itself positioned as a pioneering leader in the pharmaceutical industry.
